Oxidative stress, including DNA damage and malondialdehyde, was associated with dementia in patients with chronic obstructive pulmonary disease (COPD).
Patients with chronic obstructive pulmonary disease (COPD) were found to have an association with the condition of dementia through oxidative stress, which includes malondialdehyde (MDA) and DNA damage. The study, published in Mutation Research – Genetic Toxicology and Environmental Mutagensis, also found there was an association between DNA damage and failure in temporal orientation, which may be an indicator of specific cognitive impairment.
The observational study had 96 participants who were aged 65 years and older, were suffering from severe COPD, and were admitted to the Pulmonary Rehabilitation Unit of the IRCCS San Raffaele Roma between January 2013 and December 2015. Demographic information, medical history, lifestyle, and frequency intake of some foods for the patients were collected using a questionnaire.
Cognitive function was assessed using the Mini-Mental State Exam (MMSE) in patients with COPD. The test included assessments on orientation, immediate recall, attention and calculation, recall, and language.
The 96 patients included in this study had a mean (SD) age of 72.0 (8.7) years and were recruited at hospital admission. All patients were classified into 2 groups where 1 group demonstrated signs of cognitive impairment (MMSE less than or equal to 24) and the other didn’t (MMSE greater than 24). The 2 groups had 17 (18%) and 79 (82%) patients respectively.
Patients with an MMSE score less than or equal to 24 demonstrated a higher level of DNA damage than patients with a higher MMSE score (22.4 [6.9] vs 18.5 [7.1]) in a borderline difference that approached statistical significance.
Patients with MMSE less than or equal to 24 also demonstrated a significant reduction in the total score in orientation, attention and calculation, and language on their assessments. There was a significant and consistent difference between the 2 groups only for temporal orientation, which was a sub-category of orientation.
The multivariate logistic regression also found a significant association between DNA damage and a lower MMSE score after adjusting for potential and actual confounders. Comet assay, a blood test, was identified as a significant and independent predictor of cognitive decline (OR, 1.097; 95% CI, 1.012-1.189) in the logistic regression model. Comet assay was also the only predictor of temporal orientation (OR, 1.121; 95% CI, 1.070-1.247) meaning that patients with a lower MMSE score have a 10% higher level of DNA damage.
Patients with an MMSE less than or equal to 24 demonstrated a higher level of DNA damage when compared with participants with normal cognitive function in a meta-analysis (Ratio of Means, 1.54; 1.12-2.10).
There were some limitations to this study. For instance, there was a failure to identify differences in the 2 groups using a different measurement through the ELISA test, which could limit the results.
The researchers concluded that the results of the study combined with the meta-analysis on comet assay studies confirmed that oxidative stress, including MDA and DNA damage, was associated with dementia in patients with COPD, with a specific association between failure in temporal orientation and DNA damage.
Reference
Ilari S, Russo P, Proietti S, et al. DNA damage in dementia: evidence from patients affected by severe chronic obstructive pulmonary disease (COPD) and meta-analysis of most recent literature. Mutat Res Genet Toxicol Environ Mutagen. 2022;878:503499. doi:10.1016/j.mrgentox.2022.503499
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More